Previous Close | 3.2400 |
Open | 3.1800 |
Bid | 0.0000 x 1200 |
Ask | 0.0000 x 800 |
Day's Range | 2.8600 - 3.2500 |
52 Week Range | 0.9400 - 4.7000 |
Volume | 1,480,328 |
Avg. Volume | 1,842,742 |
Market Cap | 131.262M |
Beta (5Y Monthly) | 1.87 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.8250 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
ALBERT, AB, March 2, 2021 /CNW/ - A hearing has been scheduled before a Hearing Panel of the Investment Industry Regulatory Organization of Canada (IIROC) in the matter of Gordon Albert Malic. The hearing concerns allegations that Mr.
26, 2021 /CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will host a conference call and webcast on Friday, March 5, 2021, at 8:30 am ET to discuss a corporate update and financial results for the fourth quarter and full year 2020.
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) announced publication of an electronic poster at the CAR-TCR Summit Europe 2021 with data from a preclinical study evaluating pelareorep and chimeric antigen receptor (CAR) T cell combination therapy in solid tumors.